MarketBeat | Real-Time Financial News and Analysis

Open Main Menu Open Sidebar

Lombard Medical Company Profile (NASDAQ:EVAR)

Consensus Ratings for Lombard Medical (NASDAQ:EVAR) (?)
Ratings Breakdown: 4 Buy Rating(s)
Consensus Rating:Buy (Score: 3.00)
Consensus Price Target: $7.00 (71.15% upside)

Analysts' Ratings History for Lombard Medical (NASDAQ:EVAR)
Show:
DateFirmActionRatingPrice TargetActions
7/28/2015BTIG ResearchReiterated RatingBuy$7.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
7/28/2015Jefferies GroupLower Price TargetBuy$7.50 -> $6.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
2/27/2015BTIG ResearchSet Price TargetBuy$7.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
2/27/2015BarclaysLower Price TargetOverweight$9.00 -> $7.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
2/27/2015BTIG ResearchReiterated RatingBuy$7.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
1/20/2015Credit SuisseLower Price TargetOutperform$10.50 -> $8.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
1/9/2015BarclaysLower Price TargetOverweight$11.00 -> $9.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
9/18/2014BTIG ResearchInitiated CoverageBuy$9.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
8/21/2014BarclaysLower Price TargetOverweight$12.00 -> $11.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
7/29/2014Credit SuisseInitiated CoverageOutperformView Rating Details  Tweet This Rating  Share This Rating on StockTwits
6/30/2014Credit SuisseInitiated CoverageOutperform$10.50View Rating Details  Tweet This Rating  Share This Rating on StockTwits
5/21/2014Jefferies GroupInitiated CoverageBuy$11.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
5/20/2014BarclaysInitiated CoverageOverweight$12.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
(Data available from 8/2/2013 forward)
            As Featured by CNBC As Featured by The Wall Street Journal As Featured by MarketWatch As Featured by The Boston Globe As Featured by StockTwits As Featured by Seeking Alpha